A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus
The recent Ebola virus (EBOV) epidemic highlighted the need for effective vaccines and therapeutics to limit and prevent outbreaks. Host antibodies against EBOV are critical for controlling disease, and recombinant monoclonal antibodies (mAbs) can protect from infection. However, antibodies mediate...
Main Authors: | Yu, Wen-Han (Author), Das, Jishnu (Author), Lauffenburger, Douglas A (Author), Alter, Galit (Author) |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biological Engineering (Contributor) |
Format: | Article |
Language: | English |
Published: |
Elsevier BV,
2020-07-14T15:36:13Z.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Associations Between Antibody Fc-Mediated Effector Functions and Long-Term Sequelae in Ebola Virus Survivors
by: Dominic Paquin-Proulx, et al.
Published: (2021-05-01) -
The Role of Fc Receptors on the Effectiveness of Therapeutic Monoclonal Antibodies
by: Patricia Gogesch, et al.
Published: (2021-08-01) -
Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated Humans
by: Pramila Rijal, et al.
Published: (2019-04-01) -
Ebola GP-specific monoclonal antibodies protect mice and guinea pigs from lethal Ebola virus infection.
by: Xiangguo Qiu, et al.
Published: (2012-01-01) -
Review: Insights on Current FDA-Approved Monoclonal Antibodies Against Ebola Virus Infection
by: Olivier Tshiani Mbaya, et al.
Published: (2021-08-01)